EEP — Euroespes SA Income Statement
0.000.00%
Last trade - 00:00
HealthcareBalancedMicro Cap
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2.55 | 2.37 | 2.52 | 3.29 | 3.3 |
Cost of Revenue | |||||
Gross Profit | 2.17 | 2.11 | 2.38 | 2.17 | 1.7 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2.93 | 3.23 | 2.87 | 3.53 | 4.68 |
Operating Profit | -0.379 | -0.859 | -0.347 | -0.237 | -1.39 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.531 | -0.956 | -0.429 | -0.177 | -1.14 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.335 | -1.34 | -0.411 | -0.183 | -1.14 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -0.254 | -1.26 | -0.411 | -0.183 | -1.14 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.254 | -1.26 | -0.411 | -0.183 | -1.14 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.024 | -0.119 | -0.036 | -0.016 | -0.074 |
Dividends per Share |